Ramiven Tablets

Ramiven Tablets

Drug Name:

Ramiven Tablets

Category:

International Brand: Verzenio

Verzenio

Details

Drug Name: Abemaciclib

Category: Anticancer / CDK 4 & 6 Inhibitor

International Brand: Verzenio

Available Strengths: 50 mg, 100 mg, 150 mg, 200 mg

 

Ramiven 100mg Tablets is an advanced oral cancer medication formulated with abemaciclib, designed to treat hormone receptor-positive (HR+), HER2-negative advanced breast cancer. This targeted therapy helps stop the spread of cancer cells and is often used alongside hormonal treatments like fulvestrant or letrozole to improve long-term disease control.

Uses:

  • Commonly prescribed in combination with endocrine therapy
  • Effective in premenopausal and postmenopausal women
  • Helps slow progression in patients resistant to hormonal therapies

How it Works:

Ramiven contains abemaciclib, which selectively blocks cyclin-dependent kinases (CDK4 & CDK6). These enzymes are essential for cancer cell division.

Dosage:

  • The tablets are usually administered twice a day by mouth, regardless of meals.
  • Dosage may be modified based on patient response and side effects

Side Effects:

  • Diarrhea
  • Nausea or vomiting
  • Low white blood cell count (neutropenia)
  • Fatigue
  • Reduced appetite

Precautions:

  • Regular monitoring of liver enzymes and blood cell counts is necessary
  • Use effective contraception during and for at least 3 weeks post-treatment
  • Not recommended when pregnancy or breastfeeding
  • Let your physician know if you’ve ever experienced respiratory conditions or lung-related concerns before starting treatment.
  • Hydration and nutrition should be maintained during therapy

Contraindications:

  • Allergy or hypersensitivity to abemaciclib
  • Severe liver disease
  • Pregnancy or breastfeeding
  • Uncontrolled infections
  • Concurrent use with strong CYP3A4 inhibitors without medical supervision

Interactions:

  • Strong CYP3A4 inhibitors (e.g., ketoconazole) can increase drug levels
  • Grapefruit and grapefruit juice may interfere with metabolism
  • Use caution with anticoagulants
  • Interaction risk with other cancer therapies and immunosuppressants

Frequently Asked Questions

1. What are Ramiven Tablets?
Ramiven Tablets contain abemaciclib, a targeted anti-cancer medicine and cyclin-dependent kinase (CDK) 4/6 inhibitor. Lotus International lists Ramiven in 50 mg, 100 mg, 150 mg and 200 mg tablet strengths.

2. What are Ramiven Tablets used for?
Ramiven (abemaciclib) is used for certain patients with hormone receptor-positive (HR-positive), HER2-negative advanced or metastatic breast cancer. It may be prescribed alone or in combination with endocrine therapy, depending on the approved indication and treatment plan.

3. How does Ramiven (Abemaciclib) work?
Abemaciclib selectively inhibits CDK4 and CDK6, proteins involved in regulating cell-cycle progression. By blocking these enzymes, abemaciclib can help prevent cancer cells from progressing through the cell cycle and may slow tumour growth.

4. What strengths of Ramiven Tablets are available?
Lotus International lists Ramiven Tablets in 50 mg, 100 mg, 150 mg and 200 mg strengths. The required strength and treatment regimen depend on the indication, combination therapy and individual clinical factors. Buyers should confirm the exact presentation, packaging and availability before procurement.

5. Can international buyers source Ramiven Tablets from Lotus International?
Yes. Pharmaceutical importers, distributors, wholesalers, hospitals and procurement organizations can contact Lotus International regarding Ramiven supply, bulk quantities, product availability, packaging and export documentation. Lotus International supplies oncology medicines internationally and accepts bulk orders for pharmaceutical products.